| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |